Tengjun Biotechnology Corp. Quarterly Debt-to-equity in % from Q3 2013 to Q2 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tengjun Biotechnology Corp. quarterly Debt-to-equity history and growth rate from Q3 2013 to Q2 2023.
  • Tengjun Biotechnology Corp. Debt-to-equity for the quarter ending June 30, 2023 was 1.25K %.
Debt-to-equity, Quarterly (%)
Period Value YoY Chg Change % Date
Q2 2023 1.25K* Jun 30, 2023
Q1 2023 644* Mar 31, 2023
Q4 2022 505 Dec 31, 2022
Q3 2022 1.55K Sep 30, 2022
Q1 2020 -103 Mar 31, 2020
Q4 2019 -103 Dec 31, 2019
Q3 2019 -103 Sep 30, 2019
Q1 2014 -292 Mar 31, 2014
Q4 2013 173 Dec 31, 2013
Q3 2013 0 Sep 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.